Gastrin, cholecystokinin, and somatostatin in a laboratory experiment of patients with functional dyspepsia

Psychosomatic Medicine

Volumn 60, Issue 3, 1998, Pages 331-337

  Jonsson, Bo H ^a,c   Uvnäs Moberg, Kerstin ^a   Theorell, Töres ^a   Gotthard, Ricci ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^c STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

Cholecystokinin (CCK); Functional dyspepsia (FD); Gastrin; Somatostatin; Stress interview

Indexed keywords

CHOLECYSTOKININ; GASTRIN; SOMATOSTATIN;

ADULT; ANXIETY; ARTICLE; CHOLECYSTOKININ BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DYSPEPSIA; EMOTIONAL STRESS; FEMALE; GASTRIN BLOOD LEVEL; HORMONAL REGULATION; HUMAN; MALE; MENTAL STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SOMATOSTATIN BLOOD LEVEL;

EID: 0344505203     PISSN: 00333174     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006842-199805000-00020     Document Type: Article

References (31)

1. Talley NJ, Colin-Jones D, Koch KL: Functional dyspepsia: A classification with guidelines for diagnosis and management. Gastroenterol Int 4:145-160, 1991
2. Waldron B, Cullen PT, Kumar R, et al: Evidence for hypomotility in non-ulcer dyspepsia: A prospective multifactorial study. Gut 32:246-251, 1991
3. Nyrén O, Adami H-O, Bergström R, et al: Basal and food-stimulated levels of gastrin and pancreatic polypeptide in non-ulcer dyspepsia and duodenal ulcer. Scand J Gastroenterol 21:471-477, 1986
4. Uvnäs-Moberg K, Arn I, Theorell T, et al: Gastrin, somatostatin and oxytocin levels in patients with functional disorders of the gastrointestinal tract and their response to feeding and interaction. J Psychosom Res 35:525-533, 1991
5. Chua A, Keating J, Hamilton D, et al: Central serotonin receptors and delayed gastric emptying in non-ulcer dyspepsia. Br Med J 305:280-282, 1992
6. Chua ASB, Dinan TG, Rovati LC, et al: Cholecystokinin hyperresponsiveness in dysmotility-type nonulcer dyspepsia. Ann N Y Acad Sci 713:298-299, 1994
7. Chua ASB, Bekkering M, Rovati LC, et al: Clinical efficacy and prokinetic effect of the CCK-A antagonist loxiglumide in non-ulcer dyspepsia. Ann N Y Acad Sci 713:451-453, 1994
8. Hausken T, Svebak S, Wilhelmsen, et al: Low vagal tone and antral dysmotility in patients with functional dyspepsia. Psychosom Med 55:12-22, 1993
9. Jørgensen LS, Christiansen P, Raundahl U, et al: Autonomic nervous system function in patients with functional abdominal pain. An experimental study. Scand J Gastroenterol 28:63-68, 1993
10. Sawchenko PE, Plotsky PM, Pfeiffer SW, et al: Inhibin β in central neural pathways involved in the control of oxytocin secretion. Nature 334:615-617, 1988
11. Jonsson BH, Theorell T, Gotthard R: Symptoms and personality in patients with chronic functional dyspepsia. J Psychosom Res 39:93-102, 1995
12. Gotthard R, Bodemar G, Brodin U, et al: Treatment with cimetidine, antacid, or placebo in patients with dyspepsia of unknown origin. Scand J Gastroenterol 23:7-18, 1988
13. Colin-Jones DG: Management of dyspepsia: Report of a working party. Lancet i:576-579, 1988
14. Svedlund J, Sjödin I, Dotevall G: GSRS - A clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 33:129-134, 1988
15. Dimenäs E, Glise H, Hallerbäck B, et al: Quality of life in patients with upper gastrointestinal symptoms. An improved evaluation of treatment regimens? Scand J Gastroenterol 28: 681-687, 1993
16. Mittelmann B, Wolff HG: Emotions and gastroduodenal function. Experimental studies on patients with gastritis, duodenitis and peptic ulcer. Psychosom Med 4:5-61, 1942
17. Almy TP: The stress interview: Unfinished business. J Hum Stress 1978:4:3-8, 1978
18. Svensson JC, Theorell T: Cardiovascular effects of anxiety induced by interviewing young hypertensive male subjects. J Psychosom Res 26:359-370, 1982
19. Dimsdale JE, Stern MJ, Dillon E: The stress interview as a tool for examining physiological reactivity. Psychosom Med 50:64-71, 1988
20. Nilsson G: Increased plasma gastrin levels in connection with inhibition of gastric acid response to sham feeding following bulbar perfusion with acid in dogs. Scand J Gastroenterol 10:273-277, 1975
21. Himeno S, Tarui S, Kanayama S, et al: Plasma cholecystokinin responses after ingestion of liquid meal and intraduodenal infusion of fat, amino acids, or hydrochloric acid in man: analysis with region specific radioimmunoassay. Am J Gastroenterol 78:703-707, 1983
22. Efendic S, Enzmann F, Nylén A, et al: Sulphonylurea (Glibenclamide) enhances somatostatin and inhibits glucagon release induced by arginine. Acta Physiol Scand 108:231-233, 1980
23. Philipp E, Wilckens T, Friess E, et al: Cholecystokinin, gastrin and stress hormone responses in marathon runners. Peptides 13:125-128, 1992
24. Ødum L, Petersen HD, Andersen IB, et al: Gastrin and somatostatin in Helicobacter pylori infected antral mucosa. Gut 35:615-618, 1994
25. Silber M, Larsson B, Uvnäs-Moberg K: Oxytocin, somatostatin, insulin and gastrin concentrations vis-à-vis late pregnancy, breastfeeding and oral contraceptives. Acta Obstet Gynecol Scand 70:283-289, 1991
26. Lindstedt G, Bengtsson C, Lapidus L, et al: Hypergastrinemia - A risk factor for myocardial infarction? Clin Chem 31: 585-590, 1985
27. Nomura T, Fukudo S, Muranaka M, et al: Impact of stress on serum gastrin in Zollinger-Ellison syndrome. Am J Gastroenterol 88:1432-1435, 1993
28. Liddle RA, Morita ET, Conrad CK, et al: Regulation of gastric emptying in humans. J Clin Invest 77:992-996, 1986
29. Kellow JE, Phillips SF, Miller LJ, et al: Dysmotility of the small intestine in irritable bowel syndrome. Gut 29:1236-1243, 1988
30. Harvey RF, Read AE: Effect of cholecystokinin on colonic motility and symptoms in patients with irritable bowel syndrome. Lancet i:1-3, 1973
31. Kaneko H, Mitsuma T, Uchida K, et al: Immunoreactive-somatostatin, substance P, and calcitonin gene-related peptide concentrations of the human gastric mucosa in patients with nonulcer dyspepsia and peptic ulcer disease. Am J Gastroenterol 88:898-904, 1993